PropertyValue
?:abstract
  • A 69‐year‐old man with a history of type 2 diabetes and high blood pressure was diagnosed with coronavirus disease 2019 (COVID‐19). He had hyperferritinaemia and respiratory failure. Despite the initiation of favipiravir and high‐dose corticosteroid and ceftriaxone, his respiratory failure progressed and serum ferritin levels increased. After polymyxin B‐immobilized fibre column direct haemoperfusion (PMX‐DHP) therapy, there was improvement of the respiratory failure and hyperferritinaemia. We report the first case of COVID‐19‐induced hyperferritinaemia and severe respiratory failure successfully treated by PMX‐DHP.
?:creator
?:doi
?:doi
  • 10.1002/rcr2.679
?:journal
  • Respirol_Case_Rep
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/a6b2460804131864d969a7b72e0000e528ee917b.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7604553.xml.json
?:pmcid
?:pmid
?:pmid
  • 33163186.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID‐19
?:type
?:year
  • 2020-11-01

Metadata

Anon_0  
expand all